Medicare Enrolled

Dr. Christopher Whitty, M.D., PH.D

Neurology · Riverview, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
17515 FORT ST, Riverview, MI 48193
7342257770
In practice since 2006 (20 years)
NPI: 1457339574 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Whitty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Whitty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Whitty

Dr. Christopher Whitty is a neurology specialist in Riverview, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Whitty performed 1,241 Medicare services across 971 unique beneficiaries.

Between the years covered by Open Payments, Dr. Whitty received a total of $5,712 from 50 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Whitty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 13% volume in MI $5,712 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,241
Medicare services
Top 13% in MI for neurology
971
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
266 $90 $150
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
260 $65 $89
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
195 $108 $165
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
98 $73 $160
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
97 $122 $210
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $61 $100
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
81 $45 $124
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
44 $37 $47
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
29 $143 $242
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
25 $171 $353
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
20 $98 $124
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
17 $356 $716
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
14 $140 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,712
Total received (2018-2024)
Avg $816/year across 7 years
Top 30% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
304
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,638 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$74 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,292
2023
$712
2022
$836
2021
$639
2020
$334
2019
$891
2018
$1,008

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$229
UCB, Inc.
$200
ANI Pharmaceuticals, Inc.
$146
PFIZER INC.
$104
ABBVIE INC.
$101
MDD US Operations, LLC
$66
Neurelis, Inc.
$61
Eisai Inc.
$54
AstraZeneca Pharmaceuticals LP
$45
ACADIA Pharmaceuticals Inc
$43
Novartis Pharmaceuticals Corporation
$37
MITSUBISHI TANABE PHARMA AMERICA, INC.
$34
Teva Pharmaceuticals USA, Inc.
$31
Amneal Pharmaceuticals LLC
$29
Avadel CNS Pharmaceuticals, LLC
$24
Neurocrine Biosciences, Inc.
$23
Sumitomo Pharma America, Inc.
$22
EMD Serono, Inc.
$22
Lilly USA, LLC
$22
Top 3 companies account for 44.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$491
Biogen, Inc.
$442
Amneal Pharmaceuticals LLC
$356
Teva Pharmaceuticals USA, Inc.
$319
ACADIA Pharmaceuticals Inc
$252
ABBVIE INC.
$242
US WorldMeds, LLC
$239
GENZYME CORPORATION
$238
Allergan Inc.
$233
PFIZER INC.
$215
Novartis Pharmaceuticals Corporation
$187
Neurocrine Biosciences, Inc.
$185
Supernus Pharmaceuticals, Inc.
$175
AbbVie Inc.
$161
Genentech USA, Inc.
$157
ANI Pharmaceuticals, Inc.
$146
MDD US Operations, LLC
$127
Amgen Inc.
$108
AstraZeneca Pharmaceuticals LP
$103
Eisai Inc.
$97
Sunovion Pharmaceuticals Inc.
$95
Allergan, Inc.
$91
Lilly USA, LLC
$86
Acorda Therapeutics, Inc
$74
EMD Serono, Inc.
$71
Biohaven Pharmaceutical Holding Company Ltd.
$65
Neurelis, Inc.
$61
Celgene Corporation
$56
Impax Laboratories, Inc.
$54
Adamas Pharmaceuticals, Inc.
$47
Horizon Therapeutics plc
$42
ARGENX US, INC.
$42
Bausch Health US, LLC
$40
SK Life Science, Inc.
$39
Avanir Pharmaceuticals, Inc.
$37
MITSUBISHI TANABE PHARMA AMERICA, INC.
$34
EISAI INC.
$33
E.R. Squibb & Sons, L.L.C.
$32
CATALYST PHARMACEUTICALS, INC.
$29
Kyowa Kirin, Inc.
$26
Avadel CNS Pharmaceuticals, LLC
$24
Avion Pharmaceuticals
$24
Sumitomo Pharma America, Inc.
$22
LivaNova USA, Inc.
$20
Medtronic USA, Inc.
$19
Alnylam Pharmaceuticals Inc.
$18
Vertical Pharmaceuticals, LLC
$16
Biohaven Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
GE Healthcare
$14
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · COPAXONE · CREXONT · Dhivy · EMGALITY · FIRDAPSE · Fycompa · GOCOVRI · INBRIJA · INGREZZA · KESIMPTA · LUMRYZ · Leqembi · MAYZENT · MIGRANAL · Mavenclad · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · OSMOLEX ER · Ongentys · PAXLOVID · PURIFIED CORTROPHIN GEL · QULIPTA · RADICAVA · RYTARY · Rystiggo · Solitaire · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VYVGART · Vimpat · XARELTO · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Riverview?
Compare neurologists in the Riverview area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
217
Per 100K population
12.2
County median income
$59,521
Nearest hospital
COREWELL HEALTH TRENTON HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Whitty is a clinical cardiology specialist, with above-average Medicare volume (top 13% in MI), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Whitty experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Whitty performed 266 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Whitty receive payments from pharmaceutical companies?
Yes. Dr. Whitty received a total of $5,712 from 50 companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Whitty's costs compare to other neurologists in Riverview?
Dr. Whitty's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Whitty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →